Related Experiment Videos
Structural analysis and modeling of a synthetic interleukin-2 mimetic and its interleukin-2Rbeta2 receptor
Thierry Rose1, Jean-Louis Moreau, Ralph Eckenberg
1Département de Biologie Structurale et Chimie, Institut Pasteur, 28 rue du Dr. Roux, 75724 Paris Cedex 15, France.
Abstract:
Peptide p1-30, which is composed of the 30 amino-terminal residues (alpha-helix A) of human interleukin-2 (IL-2), binds as a tetramer to the dimeric IL-2Rbeta2 receptor, whereas the entire IL-2 recognizes the tricomponent receptor IL-2Ralphabetagamma. p1-30 is an IL-2 mimetic that activates CD8 low lymphocytes and natural killer cells, because these cells produce IL-2Rbeta constitutively. It also induces a strong lymphokine-activated killer cell response. A series of truncated peptides were analyzed by circular dichroism and analytical centrifugation to elucidate the role of p1-30 residues. We propose a model where residues 10-30 of the p1-30 peptide form an alpha-helix with eight hydrophobic side chains on the same surface buried in a hydrophobic core when four anti-parallel helices combine to form a bundle. IL-2Rbeta dimerization was further studied, and three-dimensional models of the free IL-2Rbeta2 receptor and the p1-304.IL-2Rbeta2 complex were built by comparative modeling based on the crystal structure of the erythropoietin receptor complex, because this belongs to the same hematopoietin family as IL-2. These models suggest that binding of the p1-30 tetramer rotates the COOH-terminal domains and brings both transmembrane regions 50 A closer together, driving the association of the two intracytoplasmic domains that would transduce the signal into the cytoplasm.
Insights
The p1-30 peptide, a fragment of interleukin-2 (IL-2), mimics IL-2's function by binding to the IL-2 receptor beta chain (IL-2Rbeta2). This interaction activates immune cells and provides insights into IL-2 receptor signaling pathways.
Area of Science:
- Immunology
- Molecular Biology
- Structural Biology
Background:
- Interleukin-2 (IL-2) is a cytokine crucial for immune responses.
- IL-2 signals through a heterotrimeric receptor complex (IL-2Ralphabetagamma).
- The IL-2 receptor beta chain (IL-2Rbeta) dimerizes upon ligand binding.
Purpose of the Study:
- To investigate the structure-function relationship of the IL-2 mimetic peptide p1-30.
- To elucidate the mechanism of IL-2Rbeta2 receptor dimerization induced by p1-30.
- To model the IL-2Rbeta2 complex and understand signal transduction.
Main Methods:
- Circular dichroism and analytical centrifugation to analyze truncated peptides.
- Comparative modeling based on erythropoietin receptor crystal structures.
- Three-dimensional model construction of IL-2Rbeta2 and p1-304.IL-2Rbeta2 complexes.
Main Results:
- Peptide p1-30 forms an alpha-helical bundle, with residues 10-30 critical for structure.
- p1-30 tetramers bind to dimeric IL-2Rbeta2, activating CD8+ T cells and natural killer cells.
- Models suggest p1-30 binding induces IL-2Rbeta2 dimerization by rotating domains and bringing transmembrane regions closer.
Conclusions:
- The p1-30 peptide acts as an IL-2 mimetic, effectively activating specific immune cells via IL-2Rbeta.
- The structural model provides a framework for understanding IL-2Rbeta dimerization and downstream signaling.
- This research offers insights into designing novel IL-2-based therapeutics.